XVIVO Heartbox and its components

Device XVIVO Perfusion Inc.
Total Payments
$1.6M
Transactions
37
Doctors
7
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $1.6M 36 7
2023 $15,100 1 0

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $1.6M 37 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
PRESERVE Heart Study XVIVO Perfusion Inc. $1.6M 7
PRESERVE Heart Trial XVIVO Perfusion Inc. $27,940 0
IDE Heart Study XVIVO Perfusion Inc. $15,100 0

Top Doctors Receiving Payments for XVIVO Heartbox and its components

Doctor Specialty Location Total Records
Unknown — Nashville, TN $1.6M 20
, MD Vascular Surgery Birmingham, AL $5,250 3
, M.D Advanced Heart Failure and Transplant Cardiology Washington, DC $4,125 3
, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Atlanta, GA $4,125 3
, MD Vascular Surgery Birmingham, AL $3,500 2
, M.D Thoracic Surgery (Cardiothoracic Vascular Surgery) Rochester, MN $2,625 3
, MD Cardiovascular Disease Weston, FL $2,250 2
Marian Urban Thoracic Surgery (Cardiothoracic Vascular Surgery) Omaha, NE $115.10 1

Manufacturing Companies

Product Information

  • Type Device
  • Total Payments $1.6M
  • Total Doctors 7
  • Transactions 37

About XVIVO Heartbox and its components

XVIVO Heartbox and its components is a device associated with $1.6M in payments to 7 healthcare providers, recorded across 37 transactions in the CMS Open Payments database. The primary manufacturer is XVIVO Perfusion Inc..

Payment data is available from 2023 to 2024. In 2024, $1.6M was paid across 36 transactions to 7 doctors.

The most common payment nature for XVIVO Heartbox and its components is "Unspecified" ($1.6M, 100.0% of total).

XVIVO Heartbox and its components is associated with 3 research studies, including "PRESERVE Heart Study" ($1.6M).